APA (7th ed.) Citation

C, V., AH, P., & MM, R. (2026). Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer. Breast (Edinburgh, Scotland), 85, 104696. https://doi.org/10.1016/j.breast.2026.104696

Chicago Style (17th ed.) Citation

C, Valenza, Partridge AH, and Regan MM. "Optimizing Adjuvant Endocrine Therapy in Premenopausal Patients with HER2-positive, Hormone Receptor-positive Breast Cancer." Breast (Edinburgh, Scotland) 85 (2026): 104696. https://doi.org/10.1016/j.breast.2026.104696.

MLA (9th ed.) Citation

C, Valenza, et al. "Optimizing Adjuvant Endocrine Therapy in Premenopausal Patients with HER2-positive, Hormone Receptor-positive Breast Cancer." Breast (Edinburgh, Scotland), vol. 85, 2026, p. 104696, https://doi.org/10.1016/j.breast.2026.104696.